Abingworth

The London-based investment firm closes latest fund above target.

View the latest capital raises

Many investors in the Abingworth Clinical Co-Development Fund were family offices and funds of funds.

Abingworth has closed a record £300 million fund, which will target life sciences investments in Europe and North America.

In its fourth appointment in two months, Abingworth Management has recruited Sarah Shackleton to develop industry relationships and help portfolio companies recruit managers.

Abingworth Management, the venture capital firm specialising in life science, has appointed Joe Anderson as manager of its investments in quoted development-stage biotech firms.

Former Bioscience Managers director Michelle Doig has been hired by Abingworth Management to advise the firm on funding and refinancing its portfolio companies.

The UK life sciences investor has appointed two London-based entrepreneurs-in-residence to assist with portfolio companies and identify new investment targets.

Ares Management's second acquisition in under three years makes sense for both parties. Plus: LPs seeking liquidity are keeping the secondaries market ticking over; and Hawaii is hungry for (a little) more private equity. Here's today's brief, for our valued subscribers only.

The high cost of operations, capital constraints and an attraction to specialists are all factors driving M&A activity among PE firms.

Dedicated life sciences firms with strong AUM growth have been prime targets for larger GPs recently – here's a list of firms ranked by capital raised.

Horizon Capital's Lenna Koszarny discusses the Ukrainian firm's efforts to safeguard staff and portco employees in the wake of Russia's invasion. Plus: Apollo has become the latest firm to snap up a life sciences unit and Onex warns fundraising could take longer than usual. Here's today's brief, for our valued subscribers only.

Apollo Global Management's appointment of three ex-BlackRock executives highlights the rising demand for secondaries talent in today's private equity market. Plus: Carlyle is the latest PE giant to complete a life sciences acquisition and another Japanese LP wants to make a big impact. Here's today's brief, for our valued subscribers only.

Data from the Electoral Commission shows industry names, including KKR’s Johannes Huth and Warburg Pincus’ Joseph Schull, are not leaving the outcome of the upcoming referendum to chance.

Environmental Technologies Fund is blazing a green trail with its debut cleantech fund offering for institutional investors.

The former head of 3i Asia will preside over a review of SME funding in the UK and decide whether a state-backed equity investor will be needed to boost the economy. 3i was founded in 1945 under similar circumstances.